Terroir 1996 banner
IVES 9 IVES Conference Series 9 “Gheo” per la vitivinicoltura: un progetto per la produzione dl vini dl alta qualità

“Gheo” per la vitivinicoltura: un progetto per la produzione dl vini dl alta qualità

Abstract

Il settore primario, ed in particolare quello agricolo, sta attraversando un periodo partico­larmente delicato. Sia gli aspetti della produzione che quelli della commercializzazione ven­gono infatti messi in discussione da nuovi indirizzi economici e tecnologici. Prioritaria è l’e­sigenza di disporre di prodotti la cui qualità sia globale cosi definita sia per le caratteristiche intrinseche del prodotto che per la compatibilità nei confronti dell’ambiente delle tecniche utilizzate per la sua produzione. Altrettanto importante è la tipicità del prodotto, ovvero la non riproducibilità in ambienti diversi delle stesse caratteristiche organolettiche, unica garanzia nei confronti di un mercato sempre più aperto. Le colture tipiche di alta qualità rap­presentano quindi il futuro per un’agricoltura che sarà sempre meno assistita.

DOI:

Publication date: March 2, 2022

Issue: Terroir 1998

Type: Article

Authors

GIANNI BRACCINl (1), FABIO PRIMAVERA (2)

(1) CAR-TECH Firenze S.r.l. – 055601313 – Via di Coverciano, 11 – 50135 FIRENZE
(2) Via della Società Operaia, 3 – 52100 AREZZO

Tags

IVES Conference Series | Terroir 1998

Citation

Related articles…

Effects of management and seed mixture on species composition of vineyard inter-row vegetation, soil characteristics and grape berry traits

Context and purpose. Viticulture has exerted a profound influence on the landscape and biodiversity of numerous countries for centuries.

In search of the taste of terroir – a challenge for sensory science

The definition of terroir has evolved throughout history, from something clearly negative in the XVIth-XVIIIth century to a complex multi-parametric construct with positive connotations but also with many scientific unknowns. Terroir has always been linked more or less explicitly to the sensory properties of the resulting products.

EXPLORING THE INFLUENCE OF S. CEREVISIAE MANNOPROTEINS ON WINE ASTRINGENCY AND THE IMPACT OF THEIR POLYSACCHARIDE STRUCTURE

Mannoproteins (MPs) are proteoglycans from the outmost layer of yeast cell walls released into wine during alcoholic fermentation and ageing on lees processes. The use of commercial preparations of mannoproteins as additives to improve wine stability with regards to the crystallization of tartaric salts and to prevent protein haze in the case of white and rosé wines is authorized by the OIV.
Regarding red wines and polyphenols, mannoproteins are described as able to improve their colloidal stability and modulate the astringent effect of condensed tannins. The latter interact with salivary proteins forming insoluble aggregates that cause a loss of lubrication in the mouth and promote a drying and puckering sensation. However, neither the interaction mechanisms involved in mannoproteins capacity to impact astringency nor the structure-function relationships related to this property are fully understood.

Dialing in grapevine water stress indicators to better reflect holistic stress responses

Current remote sensing strategies rely heavily on reflectance data and energy balance modelling using thermal imagery to estimate crop water use and stress. These approaches show great promise for driving precision management decisions, but still require work to better understand how detected changes relate to meaningful physiological changes. Under water stress, grapevines exhibit a range of responses involving both biological and physical changes within leaves and canopies.

Mechanistic insights into the bioavailability of oleocanthal and oleacein from olive oil in presence of wine active peptides and amino acids

Oleocanthal (OC) and oleacein (OL) are highly bioactive secoiridoids found in olive oil at elevated concentrations, especially when it is produced from unripe olives (Olea europaea L.). Both compounds have been correlated with strong activities against serious diseases through recent clinical trials. The most important clinical trials have been performed in patients against chronic lymphocytic